This compound is a triazole derivative featuring a hydroxymethyl substituent. It is primarily utilized as an intermediate in the synthesis of other chemical entities.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 135242-93-2
Fmoc-L-cysteine
peptide synthesis intermediate
3-Bromo-6-chloroimidazo[1,2-b]pyridazine
pharmaceutical intermediate
1-(Dimethylamino)-3-[2-[2-(3-methoxyphenyl)ethyl]phenoxy]-2-propanol hydrochloride
Sarpogrelate intermediate
2beta,16beta-Bis(piperidin-1-yl)-5alpha-androstane-3alpha,17beta-diyl diacetate
pharmaceutical intermediate
(1-methyl-1H-1,2,4-triazol-3-yl)methanamine hydrochloride
pharmaceutical intermediate
3-(chloromethyl)-1-methyl-1H-1,2,4-triazole hydrochloride
pharmaceutical intermediate
Guanazole
research compound
1-(1H-1,2,4-triazol-1-yl)ethan-1-one
Pharmaceutical intermediate
(1-methyl-1,2,4-triazol-3-yl)methanol
WEDYTSQNYJKOPC-UHFFFAOYSA-N
CN1C=NC(=N1)CO
—